Cargando…
Predicting outcome in patients with sepsis: new biomarkers for old expectations
Early prediction of the outcome of patients with sepsis could be helpful in guiding therapies but remains challenging. Presepsin, a new sepsis biomarker whose elevation as early as day 1 is well correlated with 28-day mortality, could be considered to this end.
Autores principales: | Charles, Pierre-Emmanuel, Gibot, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056609/ https://www.ncbi.nlm.nih.gov/pubmed/24517597 http://dx.doi.org/10.1186/cc13723 |
Ejemplares similares
-
On the origins of lactate during sepsis
por: Gibot, Sébastien
Publicado: (2012) -
Urine sTREM-1 assessment in diagnosing sepsis and sepsis-related acute kidney injury
por: Derive, Marc, et al.
Publicado: (2011) -
Apolipoprotein M - a new biomarker in sepsis
por: Christoffersen, Christina, et al.
Publicado: (2012) -
PSP/reg: a new stone in sepsis biomarkers?
por: Busani, Stefano, et al.
Publicado: (2012) -
Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers
por: Hobson, Michael J, et al.
Publicado: (2011)